Sony and Astellas Pharma Enter into Collaborative Research Agreement
By, Admin1 min read
Share
Sony Corporation and Astellas Pharma announced that they have entered into a collaborative research agreement to discover a novel Antibody-Drug Conjugate (ADC)* platform in oncology based on Sony
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
